Hello.
Hi, thank you for the opportunity. My first question is to Dr. Patel. Can you comment on the Mirabegron litigation update which we recently heard and what is your view on the supplies from your perspective? 7 of 22
Questions across 1 call
Damyanti Kerai
Firm not listed in source transcripts